Intrinsic Value

The intrinsic value of Cannabis Bioscience International Holdings Inc (CBIH) under the Base Case is 0.0001 USD per share. Compared with the current market price of 0.0001 USD, the stock appears Overvalued by 8% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

CBIH Intrinsic Value
$0.0001
Overvaluation 8%
Intrinsic Value
Price $0.0001
C

CBIH is cheaper than usual. Still overvalued, but less so than on 82% of days in the past 3 years.

Monitor CBIH
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0
Get notified when the price drops into your buy zone
Current Price $0
Margin of Safety 20% $0
Intrinsic Value $0
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CBIH

Fundamental Analysis

What Cannabis Bioscience International Does

Life Sciences Tools & Services Health Care

Cannabis Bioscience International Holdings, Inc. engages in the provision of services in therapeutic areas of clinical research. The company is headquartered in Houston, Texas and currently employs 389 full-time employees. The company went IPO on 2009-09-25. The firm operates through three businesses: the Pharmacology University Business, the Alpha Research Business, and the Alpha Fertility and Sleep Center (AFSC) Business.

Headquarters
United States of America US
Employees
389
IPO date
Sep 25, 2009
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Cannabis Bioscience International Holdings Inc

Efficiency

Earnings Waterfall
Cannabis Bioscience International Holdings Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one CBIH stock?

The intrinsic value for Cannabis Bioscience International Holdings Inc (CBIH) under the Base Case is 0.0001 USD.

Is CBIH stock undervalued or overvalued?

Compared with the current market price of 0.0001 USD, the stock appears Overvalued by 8% .

Back to Top